Hemoglobin-induced endothelial cell permeability is controlled, in part, via a myeloid differentiation primary response gene-88-dependent signaling mechanism

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 4, 2013, Pages 619-626

  Lisk, Christina ^a   Kominsky, Doug ^a   Ehrentraut, Stefan ^a   Bonaventura, Joe ^d   Nuss, Rachelle ^a,b   Hassell, Kathryn ^b,d   Nozik Grayck, Eva ^c   Irwin, David C ^a  

^a UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hemolytic disease; MyD88; NF B; Sicklecell disease; Toll like receptors

Indexed keywords

CATALASE; FERRIC ION; FERROUS ION; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEMOGLOBIN; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL FREE SYSTEM; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; GENE ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICROVASCULAR ENDOTHELIAL CELL; MONOLAYER CULTURE; OXIDATION; OXIDATIVE STRESS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CATALASE; CELL LINE; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; HEMOGLOBINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; OXIDATION-REDUCTION; PERMEABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84886576144     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0440OC     Document Type: Article

References (32)

1. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med 2008;359:2254-2265.
2. Kato GJ, Taylor JG VI. Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Haematol 2010;148:690-701.
3. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 2004;3:152-159.
4. Buehler PW, D'Agnillo F. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid Redox Signal 2010;12:275-291.
5. Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem 2009;284:29582-29595.
6. van Uden P, Kenneth NS, Webster R, M'ller HA, Mudie S, Rocha S. Evolutionary conserved regulation of HIF-1b by NF-kB. PLoS Genet 2011;7:e1001285.
7. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 2008;412:477-484.
8. Irwin DC,McCord JM, Nozik-Grayck E, Beckly G, Foreman B, Sullivan T, White M, Crossno J Jr, Bailey D, Flores SC, et al. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxiainduced pulmonary vascular leak. Free Radic Biol Med 2009;47:55-61.
9. Kupari M, Rapola J. Reversible pulmonary hypertension associated with vitamin C deficiency. Chest 2012;142:225-227.
10. Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, Isobe K, Nagase F. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species. J Cell Biochem 2009;108:716-725.
11. Simoni J, Simoni G, Lox CD, Prien SD, Shires GT. Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells. Artif Cells Blood Substit Immobil Biotechnol 1997;25:193-210.
12. Buehler PW, D'Agnillo F, Hoffman V, Alayash AI. Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig. J Pharmacol Exp Ther 2007;323:49-60.
13. Manalo DJ, Buehler PW, Baek JH, Butt O, D'Agnillo F, AlayashAI. Acellular haemoglobin attenuates hypoxia-inducible factor-1alpha (HIF-1alpha) and its target genes in haemodiluted rats. Biochem J 2008;414:461-469.
14. Yeh LH, Alayash AI. Effects of cell-free hemoglobin on hypoxia-inducible factor (HIF-1alpha) and heme oxygenase (HO-1) expressions in endothelial cells subjected to hypoxia. Antioxid Redox Signal 2004;6:944-953.
15. Lin S, YinQ, ZhongQ, Lv FL, Zhou Y, Li JQ,Wang JZ, Su BY,YangQW. Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 2012;9:46.
16. Piazza M, Damore G, Costa B, Gioannini TL, Weiss JP, Peri F. Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun 2011; 17:293-301.
17. Carpenter S, O'Neill LA. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 2009;422:1-10.
18. Nicolaou G, Erridge C. Toll-like receptor-dependent lipid body formation in macrophage foam cell formation. Curr Opin Lipidol 2010;21:427-433.
19. Opitz B, Eitel J, Meixenberger K, Suttorp N. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections. Thromb Haemost 2009;102:1103-1109.
20. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004;16:3-9.
21. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
22. Irwin DC, Tissot van Patot MC, Tucker A, Bowen R. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am J Physiol Lung Cell Mol Physiol 2005;288:L849-L859.
23. Van der Heiden K, Cuhlmann S, Luong A, Zakkar M, Evans PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010;118:593-605.
24. Hayden MS, Ghosh SNF. NF-kB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012;26:203-234.
25. Rodr'guez-Jim'nez FJ, Moreno-Manzano V. Modulation of hypoxiainducible factors (HIF) from an integrative pharmacological perspective. Cell Mol Life Sci 2012;69:519-534.
26. Engebretsen BJ, Irwin D, Valdez ME, O'Donovan MK, Tucker A, van Patot MT. Acute hypobaric hypoxia (5486 M) induces greater pulmonary HIF-1 activation in Hilltop compared to Madison rats. High Alt Med Biol 2007;8:312-321.
27. Gao L, Chen Q, Zhou X, Fan L. The role of hypoxia-inducible factor 1 in atherosclerosis. J Clin Pathol 2012;65:872-876.
28. Zhu J, Mohan C. Toll-like receptor signaling pathways: therapeutic opportunities. Mediators Inflamm 2010;2010:781235-781242.
29. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO III, Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-1389.
30. Liu X, Spolarics Z.Methemoglobin is a potent activator of endothelial cells by stimulating IL-6 and IL-8 production and E-selectin membrane expression. Am J Physiol Cell Physiol 2003;285:C1036-C1046.
31. Buehler PW, Baek JH, Lisk C, Connor I, Sullivan T, Kominsky D, Majka S, Stenmark KR, Nozik-Grayck E, Bonaventura J, et al. Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism. Am J Physiol Lung Cell Mol Physiol 2012;303:L312-L326.
32. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2007;2:e1364.